High Expressionof PSM-ECorrelatedWithTumor GradeinProstateCancer:ANewAlternativelySpliced

Kai-Yuan Cao, Xiao-Peng Mao, Dao-Hu Wang, Lin Xu, Guang-Qing Yuan, Shu-Qin Dai, Bo-Jian Zheng, and Shao-Peng Qiu* ResearchCentre for Clinical Laboratory Standard, Zhongshan SchoolofMedicine, SunYat-SenUniversity,Guangdong,China DepartmentofUrology,The First Aff|liatedHospital, SunYat-SenUniversity,Guangdong,China Departmentof Immunology, Zhongshan SchoolofMedicine, SunYat-SenUniversity,Guangdong,China DepartmentofMicrobiology,TheUniversityofHongKong,HongKong,China

[1]  Dianqing Wu,et al.  Prostate-Specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal Transduction , 2006, Molecular and Cellular Biology.

[2]  Shankar Vallabhajosula,et al.  Phase I trial of 177lutetium-labeled J591, a monoclonal antibody to prostate-specific membrane antigen, in patients with androgen-independent prostate cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. Klein,et al.  Novel role of prostate-specific membrane antigen in suppressing prostate cancer invasiveness. , 2005, Cancer research.

[4]  M. Silva,et al.  A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer , 2004, Cancer Research.

[5]  W. Heston,et al.  Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer , 2004, Journal of cellular biochemistry.

[6]  D. O’Keefe,et al.  Comparative analysis of prostate‐specific membrane antigen (PSMA) versus a prostate‐specific membrane antigen‐like gene , 2004, The Prostate.

[7]  Thomas D. Schmittgen,et al.  Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients , 2003, International journal of cancer.

[8]  K. Buetow,et al.  Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. , 2003, Cancer research.

[9]  S. Cingarlini,et al.  Anti‐tumor effects of toxins targeted to the prostate specific membrane antigen , 2002, The Prostate.

[10]  S. Vallabhajosula,et al.  The utility of monoclonal antibodies in the imaging of prostate cancer. , 2002, Seminars in urologic oncology.

[11]  T. Stamey,et al.  Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasia. , 2001, The Journal of urology.

[12]  Christopher J. Lee,et al.  Genome-wide detection of alternative splicing in expressed sequences of human genes , 2001, Nucleic Acids Res..

[13]  V. Reuter,et al.  Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. , 2001, Urology.

[14]  E. Holmes.  PSMA specific antibodies and their diagnostic and therapeutic use , 2001, Expert opinion on investigational drugs.

[15]  B. Tombal,et al.  Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value? , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  C. Botev,et al.  Naked DNA and Adenoviral Immunizations for Immunotherapy of Prostate Cancer: A Phase I/II Clinical Trial , 2000, European Urology.

[17]  R L Sokoloff,et al.  A dual‐monoclonal sandwich assay for prostate‐specific membrane antigen: Levels in tissues, seminal fluid and urine , 2000, The Prostate.

[18]  V. Reuter,et al.  Prostate-specific membrane antigen is produced in tumor-associated neovasculature. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  V. Reuter,et al.  Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature. , 1999, Cancer research.

[20]  D. Bostwick,et al.  Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen , 1998, Cancer.

[21]  N. Nowak,et al.  Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. , 1998, Biochimica et biophysica acta.

[22]  R. Wolfert,et al.  Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line. , 1998, Cancer research.

[23]  D. Bostwick,et al.  Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. , 1998, Urology.

[24]  A. Markham,et al.  Prostate-specific membrane antigen , 2017, Radiopaedia.org.

[25]  A. Partin,et al.  Comparison of serum PSMA, PSA levels with results of cytogen‐356 ProstaScint® scanning in prostatic cancer patients , 1997, The Prostate.

[26]  J. Nakayama,et al.  Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. , 1997, Cancer research.

[27]  N. Rawlings,et al.  Structure of membrane glutamate carboxypeptidase. , 1997, Biochimica et biophysica acta.

[28]  P. Schellhammer,et al.  Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. , 1996, Urology.

[29]  George L. Wright,et al.  Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids , 1995, International journal of cancer.

[30]  W. Fair,et al.  Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. , 1995, Cancer research.

[31]  A. Conversi,et al.  A COMPARATIVE ANALYSIS) , 2008 .

[32]  N. Bander,et al.  Prostate-specific Membrane Antigen (PSMA)-specific Monoclonal Antibodies in the Treatment of Prostate and Other Cancers , 2004, Cancer and Metastasis Reviews.

[33]  V. Reuter,et al.  Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy. , 2000, Molecular urology.

[34]  C. Cordon-Cardo,et al.  Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  G. Murphy,et al.  Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. , 1987, Anticancer research.

[36]  N. Dubrawsky.  Cancer statistics , 2022 .